Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    National Security
    Science & Regulatory
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Investor Forum
    BIO Asia-Taiwan

    July 15-19, 2026
    Taipei, Taiwan

    BIO Patient & Health Advocacy Summit
    BIO Patient Advocacy Changemakers Event

    October 22-23, 2026
    Washington, D.C

    BIO Asia-Taiwan
    BIO Europe

    November 9-11, 2026
    Cologne, Germany

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyNational SecurityScience & RegulatoryAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3199 results found
Expand All
Apply All
3199 results found

A Roadmap for Increasing Efficiency in the Development of New Medicines
Share
Human Health, Biotech Basics  •  Toolkit  •  July 23, 2026
The Reagan-Udall Foundation for the FDA, in collaboration with the Biotechnology Innovation Organization (BIO), just released a new report detailing how the United States can modernize the clinical trial process and make America the best place to develop new medicines.
Read More

Protect Vaccine Choices for Massachusetts Patients
Share
Human Health, Biodefense and Vaccines  •  Toolkit  •  July 23, 2026
For decades, Massachusetts allowed doctors, nurses, and pharmacists to offer every FDA-approved, CDC-recommended vaccine to their patients. But in 2023, a state council took away those choices, limiting which vaccines doctors and other providers could administer to their patients.
Read More

BIOPAC: BIO Board Member Enrollment Form
Share

Council of State Bioscience Associations
Share
Council for State Biotechnology Associations (CSBA)
.accordion h3 { background: #eee; transition: 0.3s; -moz-transition: 0.3s; -webkit-transition: 0.3s; padding: 15px 30px 15px 12px; font-size: 16px; line-height: 18px; cursor: pointer; position: relative; margin: 0 0 4px; } Image The Council of State Bioscience Associations (CSBA) is a confederation of state-based, non-profit trade organizations each governed by its own board of directors. The common mission of CSBA members is to promote public understanding and to advocate for public policies that support the responsible development of the bioscience industry. These groups are recognized by BIO as affiliate organizations in their respective states.  The contents of this listing may not be reproduced or used in any form without prior written permission from BIO.Bryan BrownExecutive DirectorPO BOX 20065Charleston, WV 25362(304) 529-0803www.biowv.org
Read More

Science & Regulatory
Share

PDUFA At-a-Glance (One Pager)
Share
Human Health, Biotech Basics  •  Toolkit  •  July 15, 2026
The Prescription Drug User Fee Act (PDUFA) is a bipartisan law enacted in 1992 that authorizes the FDA to collect user fees from biopharmaceutical companies to support the review of new medicines. These fees strengthen the overall review system but do not influence or guarantee approval of any specific drug. Congress must pass the reauthorization of PDUFA in 2027, as it does every five years.
Read More

BIO Comments on OMB Proposed Rule "Regulation for Federal Financial Assistance"
Share
Letters, Testimony & Comments  •  July 13, 2026

CSBA News, Comments, and Letters
Share
Council for State Biotechnology Associations (CSBA)

CSBA Letter to OMB
Share
Letters, Testimony & Comments  •  July 13, 2026
CSBA Letter to OMB

Are we finally ready for 340B reform?
Share
Bio.News  •  July 13, 2026
A flurry of congressional activity brings hope of 340B reform. Meanwhile, BIO comments on clinical trial reform. (665 words, 2 minutes, 40 seconds)
Read More

Pagination

  • First First page
  • Prev Previous page
  • …
  • 2
  • 3
  • 4
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO Investment and Growth Summit
BIO Partnering™ for Oncology
BIO International Convention
BIO Partnering™ at JPM Week
BIO Patient Advocacy Changemakers Events
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO